Hillhouse Investment Management, Ltd. - Net Worth and Insider Trading

Hillhouse Investment Management, Ltd. Net Worth

The estimated net worth of Hillhouse Investment Management, Ltd. is at least $271 Million dollars as of 2024-09-21. Hillhouse Investment Management, Ltd. is the 10% Owner of Apellis Pharmaceuticals Inc and owns about 3,527,152 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $115 Million. Hillhouse Investment Management, Ltd. is the 10% Owner of ArriVent BioPharma Inc and owns about 4,484,672 shares of ArriVent BioPharma Inc (AVBP) stock worth over $111 Million. Hillhouse Investment Management, Ltd. is also the 10% Owner of Enfusion Inc and owns about 4,975,183 shares of Enfusion Inc (ENFN) stock worth over $45 Million. Details can be seen in Hillhouse Investment Management, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hillhouse Investment Management, Ltd. has not made any transactions after 2024-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Hillhouse Investment Management, Ltd.

Hillhouse Investment Management, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hillhouse Investment Management, Ltd. owns 4 companies in total, including BeiGene Ltd (BGNE) , Apellis Pharmaceuticals Inc (APLS) , and China Jo-Jo Drugstores Inc (CJJD) among others .

Click here to see the complete history of Hillhouse Investment Management, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Hillhouse Investment Management, Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
BGNE	BeiGene Ltd	2016-02-02	10 percent owner
APLS	Apellis Pharmaceuticals Inc	2017-11-13	10 percent owner
CJJD	China Jo-Jo Drugstores Inc	2017-01-19	10 percent owner
		2021-10-25	10 percent owner

Hillhouse Investment Management, Ltd. Latest Holdings Summary

Hillhouse Investment Management, Ltd. currently owns a total of 3 stocks. Among these stocks, Hillhouse Investment Management, Ltd. owns 3,527,152 shares of Apellis Pharmaceuticals Inc (APLS) as of November 13, 2017, with a value of $115 Million and a weighting of 42.37%. Hillhouse Investment Management, Ltd. owns 4,484,672 shares of ArriVent BioPharma Inc (AVBP) as of January 30, 2024, with a value of $111 Million and a weighting of 41.12%. Hillhouse Investment Management, Ltd. also owns 4,975,183 shares of Enfusion Inc (ENFN) as of October 25, 2021, with a value of $45 Million and a weighting of 16.51%.

Latest Holdings of Hillhouse Investment Management, Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
APLS	Apellis Pharmaceuticals Inc	2017-11-13	3,527,152	32.50	114,632,440
AVBP	ArriVent BioPharma Inc	2024-01-30	4,484,672	24.81	111,264,712
ENFN	Enfusion Inc	2021-10-25	4,975,183	8.98	44,677,143

Holding Weightings of Hillhouse Investment Management, Ltd.

Hillhouse Investment Management, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Hillhouse Investment Management, Ltd. has made a total of 0 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years. The most-recent trade in Apellis Pharmaceuticals Inc is the acquisition of 1,428,571 shares on November 13, 2017, which cost Hillhouse Investment Management, Ltd. around $20 Million.

According to the SEC Form 4 filings, Hillhouse Investment Management, Ltd. has made a total of 1 transactions in ArriVent BioPharma Inc (AVBP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ArriVent BioPharma Inc is the acquisition of 555,555 shares on January 30, 2024, which cost Hillhouse Investment Management, Ltd. around $10 Million.

According to the SEC Form 4 filings, Hillhouse Investment Management, Ltd. has made a total of 1 transactions in Enfusion Inc (ENFN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enfusion Inc is the sale of 647,862 shares on October 25, 2021, which brought Hillhouse Investment Management, Ltd. around $10 Million.

Insider Trading History of Hillhouse Investment Management, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hillhouse Investment Management, Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Hillhouse Investment Management, Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hillhouse Investment Management, Ltd. is -10.33%. GuruFocus also compares Hillhouse Investment Management, Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Hillhouse Investment Management, Ltd. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hillhouse Investment Management, Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hillhouse Investment Management, Ltd.

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-7.34
Relative Return to S&P 500(%)	-11.01

Hillhouse Investment Management, Ltd. Ownership Network

Ownership Network List of Hillhouse Investment Management, Ltd.

No Data

Ownership Network Relation of Hillhouse Investment Management, Ltd.

Hillhouse Investment Management, Ltd. Owned Company Details

What does BeiGene Ltd do?

Who are the key executives at BeiGene Ltd?

Hillhouse Investment Management, Ltd. is the 10 percent owner of BeiGene Ltd. Other key executives at BeiGene Ltd include President and GM China Xiaobin Wu , SVP & General Counsel Chan Henry Lee , and Chief Financial Officer Julia Aijun Wang .

BeiGene Ltd (BGNE) Insider Trades Summary

Over the past 18 months, Hillhouse Investment Management, Ltd. made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 28,808 shares made by Xiaobin Wu , a net sale of 4,186 shares made by Julia Aijun Wang , and a net sale of 6,300 shares made by Lai Wang .

In summary, during the past 3 months, insiders sold 18,210 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 18,210 shares. During the past 18 months, 5,400,960 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,400,960 shares.

BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

BeiGene Ltd Insider Transactions

No Available Data

What does Apellis Pharmaceuticals Inc do?

Who are the key executives at Apellis Pharmaceuticals Inc?

Hillhouse Investment Management, Ltd. is the 10 percent owner of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .

Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary

Over the past 18 months, Hillhouse Investment Management, Ltd. made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 320,688 shares made by Pascal Deschatelets , a net sale of 493,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .

In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,334,201 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,334,201 shares.

Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Apellis Pharmaceuticals Inc Insider Transactions

No Available Data

What does China Jo-Jo Drugstores Inc do?

Who are the key executives at China Jo-Jo Drugstores Inc?

Hillhouse Investment Management, Ltd. is the 10 percent owner of China Jo-Jo Drugstores Inc. Other key executives at China Jo-Jo Drugstores Inc include Chief Operating Officer Wei Hu , Secretary Liu Yan , and director & 10 percent owner & CEO & Chairman of the Board Lei Liu .

China Jo-Jo Drugstores Inc (CJJD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of China Jo-Jo Drugstores Inc (CJJD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Jo-Jo Drugstores Inc (CJJD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

China Jo-Jo Drugstores Inc (CJJD)'s detailed insider trading history can be found in Insider Trading Tracker table.

China Jo-Jo Drugstores Inc Insider Transactions

No Available Data

What does Enfusion Inc do?

Who are the key executives at Enfusion Inc?

Hillhouse Investment Management, Ltd. is the 10 percent owner of Enfusion Inc. Other key executives at Enfusion Inc include Chief People Officer Bronwen Bastone , Chief Financial Officer Bradley Herring , and director & 10 percent owner Oleg Movchan .

Enfusion Inc (ENFN) Insider Trades Summary

Over the past 18 months, Hillhouse Investment Management, Ltd. made no insider transaction in Enfusion Inc (ENFN). Other recent insider transactions involving Enfusion Inc (ENFN) include a net sale of 103,589 shares made by Dan Groman , a net sale of 67,049 shares made by Bronwen Bastone , and a net sale of 252,650 shares made by Oleg Movchan .

In summary, during the past 3 months, insiders sold 3,219 shares of Enfusion Inc (ENFN) in total and bought 0 shares, with a net sale of 3,219 shares. During the past 18 months, 2,437,784 shares of Enfusion Inc (ENFN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,437,784 shares.

Enfusion Inc (ENFN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enfusion Inc Insider Transactions

No Available Data

Hillhouse Investment Management, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Hillhouse Investment Management, Ltd.. You might contact Hillhouse Investment Management, Ltd. via mailing address: Office #122, Windward 3 Building, Regatta Office Park, West Bay Road, Grand Cayman E9 Ky1-9006.

Discussions on Hillhouse Investment Management, Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.